Frontpage Hero

Because we care, we need to act

Annual and Sustainability Report

2017 Annual and Sustainability Report

"We have successfully launched our next-generation haemophilia products Elocta and Alprolix, and established a good position for them both in our main markets. Our track record of very strong quarter-on-quarter growth shows that we have managed to deliver consistently on our launch strategy. In the Annual Report, we have outlined how this growth will fuel our strategy to become global leaders in rare diseases, building on our capabilities and strengths within the field", says Guido Oelkers, CEO.

Annual General Meeting 2018

The Annual General Meeting was held on Wednesday, May 9, 2018 at 15:00 at Näringslivets Hus, Storgatan 19, Stockholm, Sweden.
Sobi Annual General Meeting

Press releases

Sobi™ Cycle bike ride from Mainz to Brussels raises funds, awareness for haemophilia

A team of cyclists from Sobi™ have biked from Mainz to Brussels 2-4 October to help raise funds for people with haemophilia as well as awareness about the condition.

SobiCycle 2018 is...

10/04/2018 - 14:00

Swedish Orphan Biovitrum AB (publ) (Sobi™) releases the primary efficacy results from the phase 2 study with anakinra in patients with acute gout – the anaGO study. For the primary endpoint of patient assessed pain intensity in the most affected joint there was a...

10/03/2018 - 08:00

As per 31 August 2018, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi™) amounts to 273,322,117 shares. All shares are common shares. The total number of votes is 273,322,117. The increase in the number of shares and votes results from an issue of...

08/31/2018 - 08:00

Following approvals from relevant competition authorities, Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) has completed the acquisition of the perpetual global rights to emapalumab from Novimmune SA. That Sobi had entered into an exclusive licence agreement for...

08/23/2018 - 14:15
Contact us

Sobi Head Office

info@sobi.com
+46 8 697 20 00
Tomtebodavägen 23A
SE-112 76 Stockholm, Sweden